Found: 16
Select item for more details and to access through your institution.
Symptomatic Primary Selective Immunoglobulin M Deficiency with Nonprotective Pneumococcal Titers Responsive to Subcutaneous Immunoglobulin Treatment.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Effects of particle size and enzyme supplementation on the energy value of field peas fed to growing pigs.
- Published in:
- Journal of Animal Science, 2024, v. 102, p. 693, doi. 10.1093/jas/skae234.782
- By:
- Publication type:
- Article
Synergistic Toxicities from Multiple Therapies for Synchronous Malignancies.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 45, doi. 10.1159/000529017
- By:
- Publication type:
- Article
Combination of Local Ablative Therapy and Continuation of Immune Checkpoint Inhibitor (ICI) Therapy Provides Durable Treatment Response Past Oligometastatic Progression in NSCLC: A Case Report.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 3, p. 866, doi. 10.1159/000504473
- By:
- Publication type:
- Article
Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma.
- Published in:
- Journal of Oncology, 2015, v. 2015, p. 1, doi. 10.1155/2015/181926
- By:
- Publication type:
- Article
Total and Free 25-Hydroxy-Vitamin D and Bacterial Vaginosis in Pregnant African American Women.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real World Characterization of Advanced Non–Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 260, doi. 10.1016/j.cllc.2021.01.013
- By:
- Publication type:
- Article
Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 555, doi. 10.1177/1078155220924719
- By:
- Publication type:
- Article
Nivolumab-induced hypothyoidism with consequent hypothyroid related myopathy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 1, p. 224, doi. 10.1177/1078155219835912
- By:
- Publication type:
- Article
Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 3, p. 190, doi. 10.1177/1078155217693426
- By:
- Publication type:
- Article
Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 4, p. 434, doi. 10.1080/0284186X.2020.1712473
- By:
- Publication type:
- Article
Understanding functional implication of β-casein gene variants in four cattle breeds characterized using AmpliSeq approach.
- Published in:
- 3 Biotech, 2020, v. 10, n. 9, p. N.PAG, doi. 10.1007/s13205-020-02410-2
- By:
- Publication type:
- Article
Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 75, doi. 10.2147/OTT.S68558
- By:
- Publication type:
- Article
Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab/ipilimumab.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 18, p. 7637, doi. 10.1002/cam4.2625
- By:
- Publication type:
- Article
Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up.
- Published in:
- 2019
- By:
- Publication type:
- journal article